Idiopathic Generalized Epilepsy Syndromes

Epilepsy Clinical Trial

Official title: Idiopathic Generalized Epilepsy Syndromes: Clinical Features and Long-term Outcomes

Status Recruiting

Clinical Trial Summary

The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance.

According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.

Clinical Trial Description

the Long-term prognosis include the rate of drug-resistent epilepsy, relapse after drug withdrawn, common comorbidities such as mood disorders, attention deficit hyperactivity disorder (ADHD) and learning disabilities. ;

Related Conditions & MeSH terms

• Epilepsy
• Epilepsy, Generalized
• Epilepsy, Idiopathic Generalized
• Epileptic Syndromes

• NCT number: NCT06388174
• Study type: Observational
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: Chunhong Shen
• Phone: +86 0571 87783872
• Email: shen_neurology@zju.edu.cn
• Status: Recruiting
• Start date: January 1, 2023
• Completion date: December 31, 2033